Humberto Erick De La Torre Tarazona (Erick De La Torre-Tarazona, Erick De La Torre-Tarazona)

Years Active: 2023-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Javier García-Pérez, Mercedes Bermejo, Almudena Ramírez-García, Humberto Erick De La Torre Tarazona, Almudena Cascajero, María Castillo de la Osa, Paloma Jiménez, Marta Aparicio Gómez, Esther Calonge, Aránzazu Sancho-López, Concepción Payares-Herrera, Rocio Layunta Acero, Laura Vicente-Izquierdo, Cristina Avendaño-Solá, José Alcamí, Mayte Pérez-Olmeda, Francisco Díez-Fuertes
Longer intervals between SARS-CoV-2 infection and mRNA-1273 doses improve the neutralization of different variants of concern. Journal of medical virology (2023)
Humberto Erick De La Torre Tarazona, Alba González-Robles, Almudena Cascajero, Paloma Jiménez, José María Miró, Sonsoles Sánchez-Palomino, José Alcamí, Maria José Buzón, Javier García-Pérez, null null
Treatment with integrase inhibitors alters SARS-CoV-2 neutralization levels measured with HIV-based pseudotypes in people living with HIV. Journal of medical virology (2023)
Humberto Erick De La Torre Tarazona, Alba González-Robles, Almudena Cascajero, Paloma Jiménez, José María Miró, Sonsoles Sánchez-Palomino, José Alcamí, Maria José Buzón, Javier García-Pérez, null null
Treatment with integrase inhibitors alters SARS-CoV-2 neutralization levels measured with HIV-based pseudotypes in people living with HIV. Journal of medical virology 95 (2) (2023)

Humberto Erick De La Torre Tarazona.css-eqlu8i{font-size:small;padding-left:4px;} (Erick De La Torre-Tarazona, Erick De La Torre-Tarazona)